Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
The Laryngoscope|March 30, 2023
Audiologic Follow-up in Patients With Head and Neck Cancer Treated With Cisplatin and RadiationDavid S Lee, Emma Y Travis, Susan K Wong, et al.
Cancer Research Communications|January 27, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients With Select Solid TumorsJong Chul Park, David Berz, Manish R Sharma, et al.
Plos One|July 28, 2021
Prevalence of unmasked and improperly masked behavior in indoor public areas during the COVID-19 pandemic: Analysis of a stratified random sample from Louisville, KentuckySeyed M Karimi, Sonali S Salunkhe, Kelsey B White, et al.
Cancer Research Communications|February 22, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid TumorsJong Chul Park, David Berz, Manish R Sharma, et al.
Blood Advances|April 23, 2026
I-STRONG: An integrative, multicomponent treatment approach for chronic pain in pediatric sickle cell diseaseSoumitri Sil, Jan T Mooney, Taylor R Adkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical TrialRavindra Uppaluri, Ashley E Winkler, Tianxiang Lin, et al.
Cancer Research|June 20, 2023
Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR ActivityAlison E Smith, Stacia Chan, Zhiyong Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservationM R Posner, C M Norris, L J Wirth, et al.
JAMA Oncology|June 23, 2018
Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck: The Active8 Randomized Clinical TrialRobert L Ferris, Nabil F Saba, Barbara J Gitlitz, et al.
Cell Reports. Medicine|April 2, 2026
Single-cell analysis highlights the significance of malignant cell IFN/MHC-II for immunotherapy response in head and neck squamous cell carcinomaMichael Mints, Reilly A Sample, Anuraag S Parikh, et al.
Pageof 14